Becker's Healthcare August 8, 2024
Madeline Ashley

Walgreens shared in an Aug. 7 Securities and Exchange Commission filing that it could sell off its entire stake in primary care clinic chain VillageMD.

“The company is currently evaluating a variety of options with respect to VillageMD in light of ongoing investments by the company in VillageMD’s businesses and VillageMD’s substantial ongoing and expected future cash requirement,” the filing said. “These options could include a sale of all or part of the VillageMD businesses, possible restructuring options and other strategic opportunities.”

The filings come after Walgreens saw a $5.8 billion loss in the second quarter of 2024 due to an investment devaluation in VillageMD.

Walgreens shared plans in late June to cut back on “a significant portion” of its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Primary care, Provider
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article